Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H. Miller, Charles L. Raison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 68-75
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories
Sameer Hassamal
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 163
Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry
Andrew H. Miller, Michael Berk, Gilles Bloch, et al.
Brain Behavior and Immunity (2025) Vol. 125, pp. 319-329
Closed Access | Times Cited: 2
Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study
Ashley E. Mason, Patrick Kasl, Severine Soltani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Annual Research Review: Neuroimmune network model of depression: a developmental perspective
Robin Nusslock, Lauren B. Alloy, Gene H. Brody, et al.
Journal of Child Psychology and Psychiatry (2024) Vol. 65, Iss. 4, pp. 538-567
Open Access | Times Cited: 12
Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 8
Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation
Luca Sforzini, Moira Marizzoni, Chiara Bottanelli, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 6
Metabolomics signatures of depression: the role of symptom profiles
Hilde de Kluiver, Rick Jansen, Brenda W.J.H. Penninx, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials
Sarah R. Vreijling, Cherise R. Chin Fatt, Leanne M. Williams, et al.
The British Journal of Psychiatry (2023) Vol. 224, Iss. 3, pp. 89-97
Open Access | Times Cited: 11
Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor
Takumi Nakamura, Toru Yoshihara, Chiharu Tanegashima, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 4
Neurotransmitter and metabolic effects of interferon-alpha in association with decreased striatal dopamine in a Non-Human primate model of Cytokine-Induced depression
Mandakh Bekhbat, Andrew M. Block, Sarah Y. Dickinson, et al.
Brain Behavior and Immunity (2025)
Closed Access
Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians
Danielle Ireland, Christina Rabeler, Sagar Rao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0315394-e0315394
Open Access
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Anupam Sah, Nicolas Singewald
Pharmacology & Therapeutics (2025), pp. 108825-108825
Closed Access
Anti-inflammatory interventions for the treatment and prevention of depression among older adults: a systematic review and meta-analysis
Hong Gong, Wenjun Su, Shilong Deng, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Exosomes and their roles in major depressive disorder: an overview of the research progress and perspectives
Mei Tian, Sangyoon Yi, Li Zhao, et al.
Deleted Journal (2025), pp. 100035-100035
Closed Access
Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation
Estelle Darrau, Elise Jacquemet, Stéphanie Pons, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Signatures of neuroinflammation in the hippocampus and amygdala in individuals with religious or spiritual problem
Szabolcs Kéri, Ogúz Kelemen
Religion Brain & Behavior (2024), pp. 1-13
Closed Access | Times Cited: 3
The human neurosecretome: extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications
Taliah Soleymani, Tzu-Yi Chen, Edgar Gonzalez‐Kozlova, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
A Critical View on New and Future Antidepressants
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial
Naoise Mac Giollabhui, David Mischoulon, Boadie W. Dunlop, et al.
Brain Behavior & Immunity - Health (2023) Vol. 32, pp. 100666-100666
Open Access | Times Cited: 6
Predictors of successful anti-inflammatory drug trials in patients with schizophrenia: A meta-regression and critical commentary
Anjali Chandra, Brian J. Miller, David R. Goldsmith
Brain Behavior and Immunity (2023) Vol. 114, pp. 154-162
Open Access | Times Cited: 5
The why, when, where, how, and so what of so-called rapidly acting antidepressants
Alan F. Schatzberg, Sanjay J. Mathew
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 189-196
Closed Access | Times Cited: 4
Immune-neuroendocrine patterning and response to stress. A latent profile analysis in the English longitudinal study of ageing
Odessa S. Hamilton, Eleonora Iob, Olesya Ajnakina, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 600-608
Open Access | Times Cited: 4
Dissecting depression symptoms: multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation
Jonas Hagenberg, Tanja Brückl, Mira Erhart, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Higher levels of plasma Adrenocorticotropic hormone (ACTH) are associated with lower suicidal ideation in depressed patients compared to controls and suicide attempters, independently from depression severity
Robertas Strumila, Aistė Lengvenytė, Linas Zdanavičius, et al.
Comprehensive Psychoneuroendocrinology (2024) Vol. 19, pp. 100235-100235
Open Access | Times Cited: 1
Synergistic Gold Nanorod‐based Chemo‐Photothermal Therapy: A Promising Nanoparticle Approach for Refractory Multidrug‐Resistant Cancer
Haifa A. Alqahtani, Dalal Mohamed Alshangiti, Nadiah Aldaleeli, et al.
ChemBioEng Reviews (2024) Vol. 11, Iss. 4
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top